Within amyloid program, we are finding small molecule therapeutics that can overcome the limitation of the monoclonal antibody based immunotherapies and replace them

Glia program is intended to find out novel targets and therapeutics to enhance the active glial cells and rescue the exhausted glial cells

Proteostasis pathways are essential for normal cell function including neuron, microglia and astrocyte.​
We are struggling to find out novel targets and therapeutics to maintain protein degradation machinery which is reduced in Alzheimer’ s disease